This statistic displays the top pharmaceutical R & D projects based on net present value , as of November 2019 . According to the source , the top R & D project was Eli Lilly 's diabetes drug Tirzepatide with a net present value of 11.7 billion U.S. dollars at that time . Drugs targeting cancer and autoimmune conditions are most present among the top projects .
